Treatment package time predicts cancer‑specific survival and distant metastasis in laryngeal cancer

Suzuki,Hidenori; Terada,Hoshino; Hanai,Nobuhiro; Nishikawa,Daisuke; Koide,Yusuke; Beppu,Shintaro; Kodaira,Takeshi; Tachibana,Hiroyuki; Koide,Yutaro; Tanaka,Hiroshi; Hasegawa,Yasuhisa

doi:10.3892/ol.2018.9664

January-2019 Volume 17 Issue 1

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

January-2019 Volume 17 Issue 1

Full Size Image

Article

Treatment package time predicts cancer‑specific survival and distant metastasis in laryngeal cancer

Authors:
- Hidenori Suzuki
- Hoshino Terada
- Nobuhiro Hanai
- Daisuke Nishikawa
- Yusuke Koide
- Shintaro Beppu
- Takeshi Kodaira
- Hiroyuki Tachibana
- Yutaro Koide
- Hiroshi Tanaka
- Yasuhisa Hasegawa
View Affiliations / Copyright

Affiliations: Department of Head and Neck Surgery, Aichi Cancer Center Hospital, Nagoya, Aichi 464‑8681, Japan, Department of Radiation Oncology, Aichi Cancer Center Hospital, Nagoya, Aichi 464‑8681, Japan
Pages: 1384-1390
|
Published online on: November 5, 2018

https://doi.org/10.3892/ol.2018.9664
Expand metrics +

Abstract

We investigated whether treatment package time was significantly associated with survival outcomes of resectable locally‑advanced laryngeal squamous cell carcinoma in patients who consecutively underwent various treatments, including surgery alone and salvage surgery for residual tumor. A total of 100 patients with clinical T3‑T4 resectable laryngeal squamous cell carcinoma were enrolled in this study. The treatment package time was calculated in days between the start of any treatment and the end of all treatments, including postoperative radiotherapy and salvage surgery for residual tumors. Using a log‑rank test, a treatment package time of ≥68 days showed significantly shorter cancer‑specific (P=0.0013) and distant metastasis‑free survival (P=0.0017), compared with a treatment package time of <68 days. Multivariate survival analyses of two Cox's hazards proportional models was conducted. In both model‑1, which adjusted for cT3/cT4, cN0‑1/cN2‑3 and total laryngectomy/non‑total laryngectomy, and model‑2, which adjusted for cT3/cT4, cN0‑1/cN2‑3 and induction therapy/non‑induction therapy, the cancer‑specific survival and distant metastasis‑free survival, according to treatment package time, were significantly longer with <68 days compared with ≥68 days (P<0.01). The present study demonstrated that a prolonged treatment package time is a prognostic factor for shorter cancer‑specific and distant metastasis‑free survival after various treatments for resectable locally‑advanced laryngeal cancer.

View Figures

View References

1	Sanabria A, Chaves ALF, Kowalski LP, Wolf GT, Saba NF, Forastiere AA, Beitler JJ, Nibu KI, Bradford CR, Suárez C, et al: Organ preservation with chemoradiation in advanced laryngeal cancer: The problem of generalizing results from randomized controlled trials. Auris Nasus Larynx. 44:18–25. 2017. View Article : Google Scholar : PubMed/NCBI
2	Eskiizmir G, Toker Tanyeri G, Celik O, Gunhan K, Tan A and Ellidoluz H: Predictive and prognostic factors for patients with locoregionally advanced laryngeal carcinoma treated with surgical multimodality protocol. Eur Arch Otorhinolaryngol. 274:1701–1711. 2017. View Article : Google Scholar : PubMed/NCBI
3	Semrau S, Schmidt D, Lell M, Waldfahrer F, Lettmaier S, Kuwert T, Iro H and Fietkau R: Results of chemoselection with short induction chemotherapy followed by chemoradiation or surgery in the treatment of functionally inoperable carcinomas of the pharynx and larynx. Oral Oncol. 49:454–460. 2013. View Article : Google Scholar : PubMed/NCBI
4	Sher DJ, Posner MR, Tishler RB, Sarlis NJ, Haddad RI, Holupka EJ and Devlin PM: Relationship between radiation treatment time and overall survival after induction chemotherapy for locally advanced head-and-neck carcinoma: A subset analysis of TAX 324. Int J Radiat Oncol Biol Phys. 81:e813–e818. 2011. View Article : Google Scholar : PubMed/NCBI
5	Budach W, Bölke E, Kammers K, Gerber PA, Orth K, Gripp S and Matuschek C: Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta-analysis of randomized trials. Radiother Oncol. 118:238–243. 2016. View Article : Google Scholar : PubMed/NCBI
6	Nakata Y, Ijichi K, Hanai N, Nishikawa D, Suzuki H, Hirakawa H, Kodaira T, Fujimoto Y, Fujii T, Miyazaki T, et al: Treatment results of alternating chemoradiotherapy with early assessment for advanced laryngeal cancer: A multi-institutional phase II study. Auris Nasus Larynx. 44:104–110. 2017. View Article : Google Scholar : PubMed/NCBI
7	Shaikh T, Handorf EA, Murphy CT, Murphy CT, Mehra R, Ridge JA and Galloway TJ: The impact of radiation time on survival in patients with head and neck cancer. Int J Radiat Oncol Biol Phys. 96:967–975. 2016. View Article : Google Scholar : PubMed/NCBI
8	Soyfer V, Geva R, Michelson M, Inbar M, Shacham-Shmueli E and Corm BW: The impact of overall radiotherapy treatment time and delay in initiation of radiotherapy on local control and distant metastases in gastric cancer. Radiat Oncol. 9:812014. View Article : Google Scholar : PubMed/NCBI
9	Peters LJ and Withers HR: Applying radiobiological principles to combined modality treatment of head and neck cancer-the time factor. Int J Radiat Oncol Biol Phys. 39:831–836. 1997. View Article : Google Scholar : PubMed/NCBI
10	Guttmann DM, Kobie J, Grover S, Lin A, Lukens JN, Mitra N, Rhodes KV, Feng W and Swisher-McClure S: National disparities in treatment package time for resected locally advanced head and neck cancer and impact on overall survival. Head Neck. 40:1147–1155. 2018. View Article : Google Scholar : PubMed/NCBI
11	Takehana K, Kodaira T, Tachibana H, Kimura K, Shimizu A, Makita C, Tomita N, Nishikawa D, Suzuki H, Hirakawa H, et al: Retrospective analysis of the clinical efficacy of definitive chemoradiotherapy for patients with hypopharyngeal cancer. Jpn J Clin Oncol. 46:344–349. 2016. View Article : Google Scholar : PubMed/NCBI
12	Suzuki H, Hanai N, Nishikawa D, Fukuda Y and Hasegawa Y: Complication and surgical site infection for salvage surgery in head and neck cancer after chemoradiotherapy and bioradiotherapy. Auris Nasus Larynx. 44:596–601. 2017. View Article : Google Scholar : PubMed/NCBI
13	Nakata Y, Hanai N, Nishikawa D, Suzuki H, Koide Y, Fukuda Y, Nomura M, Kodaira T, Shimizu T and Hasegawa Y: Comparison between chemoselection and definitive radiotherapy in patients with cervical esophageal squamous cell carcinoma. Int J Clin Oncol. 22:1034–1041. 2017. View Article : Google Scholar : PubMed/NCBI
14	Polesel J, Furlan C, Birri S, Giacomarra V, Vaccher E, Grando G, Gobitti C, Navarria F, Schioppa O, Minatel E, et al: The impact of time to treatment initiation on survival from head and neck cancer in north-eastern Italy. Oral Oncol. 67:175–182. 2017. View Article : Google Scholar : PubMed/NCBI
15	Ghanem AI, Mannari A, Schymick MA, Burmeister C, Ghanem T, Chang S and Siddiqui F: The effect of treatment package time in head and neck cancer patients treated with adjuvant radiation therapy and concurrent systemic therapy. Int J Radiat Oncol Biol Phys. 99:E3382017. View Article : Google Scholar

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Treatment package time predicts cancer‑specific survival and distant metastasis in laryngeal cancer

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Related Articles